The present invention relates to an orodispersible tablet comprised of, by weight:a maximum of 15%of a low-dose, therapeutically active substance；from 55% to 70% of mannitol of a particle size between 30μm to 300μm；at least 2% of maltodextrin；from 3.5% to 8% of croscarmellose sodium；from 10% to 20% of microcrystalline cellulose；from 0.5% to 1.5% of magnesium stearate； andfrom 1% to 5% of flavoring(s) and sweetener(s).本發明乃關於一種口內分散之錠劑，其包含以重量計之下列成分：最高15%之低劑量、具治療活性之物質；55%至70%甘露醇微粒，尺寸介於30μm至300μm；至少2%之麥芽糊精；3.5%至8%之交聯羧甲纖維素鈉；10%至20%之微晶纖維素；0.5%至1.5%之硬脂酸鎂；及1%至5%之香料及甜味劑。
